Ford G A, Preece J D, Davies I H, Wilkinson S P
Department of Medicine, Gloucestershire Royal Hospital, UK.
Postgrad Med J. 1992 Apr;68(798):272-6. doi: 10.1136/pgmj.68.798.272.
The SeHCAT test was used to investigate possible bile acid malabsorption in 166 patients presenting to a district general hospital with chronic diarrhoea of uncertain cause. Eighty-four (51%) patients had impaired SeHCAT retention. These included 23 of 28 patients with a possible type I abnormality (terminal ileal resection or disease, previous pelvic radiotherapy), 20 of 74 with a possible type II abnormality (idiopathic diarrhoea), 32 of 45 with a possible type III abnormality (post-cholecystectomy, post-vagotomy), and 9 of 19 with diarrhoea associated with diabetes. Patients with severe bile acid malabsorption demonstrated a good response to cholestyramine whereas the response in patients with a mildly abnormal SeHCAT retention was variable. Bile acid malabsorption is an important cause of diarrhoea in patients presenting with unexplained chronic diarrhoea.
采用硒-同型胆酸螯合剂(SeHCAT)试验,对一家地区综合医院收治的166例病因不明的慢性腹泻患者进行了可能存在的胆汁酸吸收不良情况调查。84例(51%)患者的SeHCAT潴留受损。其中包括28例可能存在I型异常(回肠末端切除或疾病、既往盆腔放疗)患者中的23例,74例可能存在II型异常(特发性腹泻)患者中的20例,45例可能存在III型异常(胆囊切除术后、迷走神经切断术后)患者中的32例,以及19例糖尿病相关腹泻患者中的9例。严重胆汁酸吸收不良的患者对考来烯胺反应良好,而SeHCAT潴留轻度异常的患者反应不一。胆汁酸吸收不良是不明原因慢性腹泻患者腹泻的重要原因。